Nicholas Hartog

1.2k total citations
24 papers, 181 citations indexed

About

Nicholas Hartog is a scholar working on Immunology, Genetics and Infectious Diseases. According to data from OpenAlex, Nicholas Hartog has authored 24 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Genetics and 7 papers in Infectious Diseases. Recurrent topics in Nicholas Hartog's work include Immunodeficiency and Autoimmune Disorders (8 papers), Blood disorders and treatments (4 papers) and Virus-based gene therapy research (3 papers). Nicholas Hartog is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (8 papers), Blood disorders and treatments (4 papers) and Virus-based gene therapy research (3 papers). Nicholas Hartog collaborates with scholars based in United States, Canada and Italy. Nicholas Hartog's co-authors include Steven Leonardo, Stephen B. Gauld, Jeremy W. Prokop, Caleb Bupp, Elizabeth Secord, Surender Rajasekaran, Élie Haddad, M. Louise Markert, Benjamin Oshrine and Jennifer W. Leiding and has published in prestigious journals such as The Journal of Immunology, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Nicholas Hartog

21 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Hartog United States 8 85 68 45 25 23 24 181
Bijun Sun China 9 99 1.2× 40 0.6× 40 0.9× 43 1.7× 19 0.8× 25 188
Nesrine Radwan Egypt 6 95 1.1× 51 0.8× 48 1.1× 38 1.5× 33 1.4× 17 165
Peter Mustillo United States 5 127 1.5× 49 0.7× 62 1.4× 22 0.9× 21 0.9× 18 184
William Rae United Kingdom 10 172 2.0× 51 0.8× 63 1.4× 28 1.1× 44 1.9× 21 270
Maddalena Migliavacca Italy 10 152 1.8× 72 1.1× 59 1.3× 25 1.0× 16 0.7× 12 308
Yeşim Yılmaz Demirdağ United States 9 102 1.2× 31 0.5× 53 1.2× 49 2.0× 31 1.3× 28 220
Sushila A. Toulmin United States 7 55 0.6× 65 1.0× 32 0.7× 49 2.0× 41 1.8× 9 188
Aaron Bodansky United States 5 66 0.8× 92 1.4× 46 1.0× 19 0.8× 6 0.3× 9 166
Uwe Kölsch Germany 10 154 1.8× 52 0.8× 71 1.6× 57 2.3× 12 0.5× 19 273
Samaneh Delavari Iran 9 110 1.3× 53 0.8× 48 1.1× 32 1.3× 22 1.0× 37 191

Countries citing papers authored by Nicholas Hartog

Since Specialization
Citations

This map shows the geographic impact of Nicholas Hartog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Hartog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Hartog more than expected).

Fields of papers citing papers by Nicholas Hartog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Hartog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Hartog. The network helps show where Nicholas Hartog may publish in the future.

Co-authorship network of co-authors of Nicholas Hartog

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Hartog. A scholar is included among the top collaborators of Nicholas Hartog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Hartog. Nicholas Hartog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chin, Aaron, Charlotte Cunningham‐Rundles, Keith Sacco, et al.. (2025). Piloting an automated query and scoring system to facilitate APDS patient identification from health systems. Frontiers in Immunology. 15. 1508780–1508780. 3 indexed citations
2.
3.
Zieba, Jacob K., Xiaopeng Li, Jerry L. Campbell, et al.. (2024). Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care. BioTech. 13(1). 1–1. 18 indexed citations
4.
Cunningham‐Rundles, Charlotte, Keith Sacco, Aaron Chin, et al.. (2024). 63 Clinical Roadmap for Implementing Results from Electronic Health Records Queries. Clinical Immunology. 262. 110005–110005. 1 indexed citations
5.
Harrington, Alexandra M., Nicholas Hartog, Eveline Y. Wu, Nicholas L. Rider, & S. Aggarwal. (2023). EE308 Estimated Annual Costs Among Patients with Activated PI3K Delta Syndrome. Value in Health. 26(6). S115–S115.
6.
Mustillo, Peter, Kathleen E. Sullivan, Iván K. Chinn, et al.. (2023). Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. Journal of Clinical Immunology. 43(2). 247–270. 22 indexed citations
7.
Hartog, Nicholas, et al.. (2022). Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency. Annals of Allergy Asthma & Immunology. 129(6). 776–783.e2. 7 indexed citations
8.
Secord, Elizabeth & Nicholas Hartog. (2022). Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID). Therapeutics and Clinical Risk Management. Volume 18. 939–944. 8 indexed citations
9.
Turner, Katy, et al.. (2022). Multifaceted approach to limit ordering of IgE food testing. Journal of Allergy and Clinical Immunology. 149(2). AB105–AB105. 1 indexed citations
10.
Hartog, Nicholas, et al.. (2021). SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics. Expert Review of Proteomics. 18(2). 105–118. 8 indexed citations
11.
Shankar, Rama, Rosemary Olivero, Cynthia L. Stenger, et al.. (2021). CCR5 and Biological Complexity: The Need for Data Integration and Educational Materials to Address Genetic/Biological Reductionism at the Interface of Ethical, Legal, and Social Implications. Frontiers in Immunology. 12. 790041–790041. 7 indexed citations
12.
Hartog, Nicholas, et al.. (2021). A single-center experience of treating 19 patients with chronic cold urticaria. The Journal of Allergy and Clinical Immunology In Practice. 9(11). 4173–4175. 2 indexed citations
13.
Hartog, Nicholas, et al.. (2021). Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction. Annals of Allergy Asthma & Immunology. 128(2). 217–218. 1 indexed citations
14.
Hartog, Nicholas, et al.. (2020). Use Of Omalizumab In Cold Urticaria Refractory To Therapy. Journal of Allergy and Clinical Immunology. 145(2). AB200–AB200.
15.
Prince, Benjamin T., Beth K Thielen, Kelli W. Williams, et al.. (2020). <p>Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease</p>. Pediatric Health Medicine and Therapeutics. Volume 11. 257–268. 5 indexed citations
16.
Hartog, Nicholas, Alan T. Davis, Jeremy W. Prokop, Andrew F. Walls, & Surender Rajasekaran. (2020). Monitoring neutrophil-to-lymphocyte ratio in patients with coronavirus disease 2019 receiving tocilizumab. Annals of Allergy Asthma & Immunology. 126(3). 306–308. 3 indexed citations
17.
Sacco, Keith, Matthew J. Smith, Sami L. Bahna, et al.. (2019). NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease. Journal of Clinical Immunology. 40(1). 191–202. 5 indexed citations
18.
Hartog, Nicholas, Kelli W. Williams, & Roshini S. Abraham. (2019). “The State of the Union”: Current and Future Perspectives on Patient-Centric Care for Primary Immunodeficiencies and Immune Dysregulatory Diseases. Frontiers in Immunology. 10. 1783–1783. 2 indexed citations
19.
Leonardo, Steven, et al.. (2010). Altered B cell Development and Anergy in the Absence of Foxp3 (143.20). The Journal of Immunology. 184(Supplement_1). 143.20–143.20. 1 indexed citations
20.
Leonardo, Steven, et al.. (2010). Altered B Cell Development and Anergy in the Absence of Foxp3. The Journal of Immunology. 185(4). 2147–2156. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bijun Sun Breakdown of academic impact, for papers by Nesrine Radwan Breakdown of academic impact, for papers by Peter Mustillo Breakdown of academic impact, for papers by William Rae Breakdown of academic impact, for papers by Maddalena Migliavacca Breakdown of academic impact, for papers by Yeşim Yılmaz Demirdağ Breakdown of academic impact, for papers by Sushila A. Toulmin Breakdown of academic impact, for papers by Aaron Bodansky Breakdown of academic impact, for papers by Uwe Kölsch Breakdown of academic impact, for papers by Samaneh Delavari
Rankless by CCL
2026